Plethora Solutions is a publicly listed speciality pharmaceutical company with a portfolio of products for the treatment and management of urological disorders.
Plethora’s mission is to acquire, develop and market (either directly or with partners) products to bring clinical benefit to patients suffering from urological disorders. By fulfilling this mission the Company will build a profitable and sustainable business and yield value growth for shareholders.
Plethora’s corporate objectives will be realised through:
- Licensing or selling rights to Plethora’s clinical stage assets in return for milestone and royalty revenue streams
- Building a profitable and growing, marketing and distribution subsidiary company The Urology Company whose product portfolio will be built by licensing and acquiring rights to products approved for the treatment and management of urological disorders in the UK market